OBJECTIVE: Some phytoestrogens are believed to have selective estrogen receptor modulator (SERM) activity with no action in the uterus but beneficial effects in the hypothalamo/pituitary unit and in the bone and are presently the focus of clinical interest. In the present experiments, the effects of the clinically used Cimicifuga racemosa (CR) extract BNO 1055 in the uterus, in the bone and on serum luteinizing hormone (LH) were compared with the effects of estradiol-17beta (E(2)) under acute and chronic conditions in ovariectomized rats. METHODS: Ovariectomized rats were treated either acutely (6 h) or chronically (3 Months) with E(2) or the CR extract. Gene expression of some estrogen-regulated genes in the metaphysis of the tibia and the uterus was determined. Furthermore, bone mineral density was measured by quantitative computer tomography. RESULTS: When given acutely, both E(2) and the CR extract inhibited LH secretion and slightly stimulated gene expression of IGF-I, collagen-1alpha1, osteoprotegerin and osteocalcin (all osteoblast products), and of tartrate-resistant acid phosphatase (TRAP, an osteoclast product) in the metaphysis of the femur. While E(2) stimulated uterine weight and expression of progesterone receptor (PR), the complement protein (C3) and IGF-I genes, and inhibited gene expression of the estrogen receptor beta (ERbeta) in the uterus, no such effect was observed under acute CR treatment. After chronic application with pelleted food over 3 Months E(2) had profound effects in the uterus on weight and gene expression (ERbeta, PR, C3 and IGF-I) which were not seen in the CR-treated animals. Within 3 Months after ovariectomy, control rats had lost more than 50% of the metaphyseal bone mass of the tibia, an effect prevented by E(2) and partially by CR supplementation. CONCLUSIONS: These data confirm the concept that the CR extract BNO 1055 contains as yet unidentified substances with SERM properties which act in the hypothalamo/pituitary unit and in the bone but not in the uterus.
OBJECTIVE: Some phytoestrogens are believed to have selective estrogen receptor modulator (SERM) activity with no action in the uterus but beneficial effects in the hypothalamo/pituitary unit and in the bone and are presently the focus of clinical interest. In the present experiments, the effects of the clinically used Cimicifuga racemosa (CR) extract BNO 1055 in the uterus, in the bone and on serum luteinizing hormone (LH) were compared with the effects of estradiol-17beta (E(2)) under acute and chronic conditions in ovariectomized rats. METHODS: Ovariectomized rats were treated either acutely (6 h) or chronically (3 Months) with E(2) or the CR extract. Gene expression of some estrogen-regulated genes in the metaphysis of the tibia and the uterus was determined. Furthermore, bone mineral density was measured by quantitative computer tomography. RESULTS: When given acutely, both E(2) and the CR extract inhibited LH secretion and slightly stimulated gene expression of IGF-I, collagen-1alpha1, osteoprotegerin and osteocalcin (all osteoblast products), and of tartrate-resistant acid phosphatase (TRAP, an osteoclast product) in the metaphysis of the femur. While E(2) stimulated uterine weight and expression of progesterone receptor (PR), the complement protein (C3) and IGF-I genes, and inhibited gene expression of the estrogen receptor beta (ERbeta) in the uterus, no such effect was observed under acute CR treatment. After chronic application with pelleted food over 3 Months E(2) had profound effects in the uterus on weight and gene expression (ERbeta, PR, C3 and IGF-I) which were not seen in the CR-treated animals. Within 3 Months after ovariectomy, control rats had lost more than 50% of the metaphyseal bone mass of the tibia, an effect prevented by E(2) and partially by CR supplementation. CONCLUSIONS: These data confirm the concept that the CR extract BNO 1055 contains as yet unidentified substances with SERM properties which act in the hypothalamo/pituitary unit and in the bone but not in the uterus.
Authors: Martin J Spiering; Lori A Urban; Donald L Nuss; Vivek Gopalan; Arlin Stoltzfus; Edward Eisenstein Journal: Plant Cell Rep Date: 2010-12-28 Impact factor: 4.570
Authors: Minerva Mercado-Feliciano; Michelle C Cora; Kristine L Witt; Courtney A Granville; Milton R Hejtmancik; Laurene Fomby; Katherine A Knostman; Michael J Ryan; Retha Newbold; Cynthia Smith; Paul M Foster; Molly K Vallant; Matthew D Stout Journal: Toxicol Appl Pharmacol Date: 2012-06-09 Impact factor: 4.219
Authors: Susan Arentz; Jason Anthony Abbott; Caroline Anne Smith; Alan Bensoussan Journal: BMC Complement Altern Med Date: 2014-12-18 Impact factor: 3.659
Authors: Stephanie L Smith-Roe; Carol D Swartz; Kim G Shepard; Steven M Bryce; Stephen D Dertinger; Suramya Waidyanatha; Grace E Kissling; Scott S Auerbach; Kristine L Witt Journal: Environ Mol Mutagen Date: 2018-04-18 Impact factor: 3.216
Authors: Nancy H Collins; Elizabeth C Lessey; Carolyn D DuSell; Donald P McDonnell; Lindsay Fowler; Wilder A Palomino; Maria J Illera; Xianzhong Yu; Bilan Mo; Angela M Houwing; Bruce A Lessey Journal: Biol Reprod Date: 2008-10-15 Impact factor: 4.285
Authors: E K Stuermer; S Sehmisch; M Tezval; H Tezval; T Rack; J Boekhoff; W Wuttke; T R W Herrmann; D Seidlova-Wuttke; K M Stuermer Journal: World J Urol Date: 2009-02-17 Impact factor: 4.226
Authors: Leila Kolios; Ann Kristin Hoerster; Stephan Sehmisch; Marie Christin Malcherek; Thomas Rack; Mohammed Tezval; Dana Seidlova-Wuttke; Wolfgang Wuttke; Klaus Michael Stuermer; Ewa Klara Stuermer Journal: Calcif Tissue Int Date: 2009-12-01 Impact factor: 4.333